1-6 of 228 Activities
In this CME Outfitters livestream symposium, expert faculty will instruct learners on the role of pro-inflammatory cytokines in the pathogenesis of IBD. Learners will be guided on the role of the IL-23/Th17 inflammatory axis in IBD pathogenesis and how to appraise the clinical implications of anti-IL-23 agents used in the treatment of IBD. Faculty will model the development of individualized treatment plans for patients with IBD that are eligible for treatment with an IL-23-targeted agent.
In this CME Outfitters live webcast, expert faculty will elucidate the importance of comprehensive therapeutic and supportive care in preventing end-organ damage and improving QoL in patients with SCD. Learners will be guided through determining the effectiveness and challenges of current therapies to address the burden of disease in patients with SCD. Faculty will discuss emerging options in SCD treatment, including the long-term efficacy and safety of new interventions and investigational agents.
In this CME Outfitters live webcast, expert faculty will assess the burden of delayed diagnosis on patients with PBC, review evidence-based strategies for early, non-invasive detection, and discuss contemporary clinical pathways for treatment, including recent FDA-approved options. The program will also emphasize interdisciplinary collaboration and shared decision-making to empower patients and improve health outcomes through informed and equitable care. Learners will be equipped with evidence-based tools to help incorporate diagnostic and treatment approaches at the point of care.
In this CME Outfitters recorded webcast, expert faculty will elucidate the importance of comprehensive therapeutic and supportive care in preventing end-organ damage and improving QoL in patients with SCD. Learners will be guided through determining the effectiveness and challenges of current therapies to address the burden of disease in patients with SCD. Faculty will discuss emerging options in SCD treatment, including the long-term efficacy and safety of new interventions and investigational agents.
In this CME Outfitters recorded webcast, expert faculty will assess the burden of delayed diagnosis on patients with PBC, review evidence-based strategies for early, non-invasive detection, and discuss contemporary clinical pathways for treatment, including recent FDA-approved options. The program will also emphasize interdisciplinary collaboration and shared decision-making to empower patients and improve health outcomes through informed and equitable care. Learners will be equipped with evidence-based tools to help incorporate diagnostic and treatment approaches at the point of care.
In the fourth activity of this CME Outfitters podcast series on gynecologic cancers, expert faculty will present and discuss the very latest research on biomarker testing, specifically for HRD positivity, for first-line treatment of OC.
